K. Macrae

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection.

D. Cooper, A. Kelleher, J. Zaunders, 2010, AIDS research and human retroviruses.

A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients

D. Cooper, S. Emery, K. Williams, 2009, Antiviral therapy.

The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation.

A. Winston, D. Cooper, M. Law, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

A Randomized Study of Pharmacokinetics, Efficacy, and Safety of 2 Raltegravir Plus Atazanavir Strategies in ART-Treated Adults

D. Cooper, H. Wand, S. Emery, 2012, Journal of acquired immune deficiency syndromes.

Financial stress is associated with reduced treatment adherence in HIV‐infected adults in a resource‐rich setting

A. Carr, J. Mcallister, E. Lavie, 2013, HIV medicine.

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.